IL-27 improves adoptive CD8+ T cells' antitumor activity via enhancing cell survival and memory T cell differentiation.
Cancer Sci
; 113(7): 2258-2271, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-35441753
Key words
Full text:
1
Database:
MEDLINE
Main subject:
CD8-Positive T-Lymphocytes
/
Interleukin-27
Limits:
Animals
Language:
En
Year:
2022
Type:
Article